Novavax Announces Proposed $125 Million Public Offering of Common Stock

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced a proposed underwritten public offering to sell up to $125 million of its common stock. In connection with the common stock offering, Novavax expects to grant to the underwriters a 30-day option to purchase up to an additional $18.75 million of its common stock at the public…

thaipr.net

15 ธ.ค. 65

Another very successful year for the ZEISS Group

Significant revenue growth of 8.8 billion euros despite challenging geopolitical and economic conditions – EBIT at 1.6 billion euros (up 109 million euros compared to the prior year). The ZEISS Group once again significantly surpassed the strong prior-year level. All four ZEISS segments have shown double-digit percentage growth Focused investment strategy with high expenditure on […]

thaipr.net

14 ธ.ค. 65
1 238 239 240 241 242 490